SynthesisOpen heart2025
Impact of depression on medication non-adherence in coronary artery disease: a systematic review and meta-analysis.
Synthesis in Open heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Documented Rheumatic Disease and Post-Discharge Mortality After Acute Coronary Syndrome: A Two-Center Registry Study.Medicina (Kaunas, Lithuania) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor cardiovascular outcomes. This may be related to medication non-adherence; a topic on which considerable new evidence has emerged. We aim to assess the relationship between depression and medication adherence in patients with CAD.
methodsThe Cochrane Library, Medline and Embase databases were searched for relevant studies published until January 2023. Studies were included if they reported the prevalence of adherence to cardiovascular medications in depressed versus non-depressed participants aged >18 years with CAD, including acute and chronic coronary syndromes and those undergoing percutaneous coronary intervention. The primary outcome was the OR of non-adherence to cardiovascular medications in depressed versus non-depressed patients.
resultsIncluded studies (n=30) comprised mainly of cohort or cross-sectional studies, most of which involved US participants. Nine tools were used to measure medication adherence, the majority of which relied on participant self-report. Nine depression diagnostic tools were used, including the Patient Health Questionnaire, Beck Depression Inventory and International Classification of Diseases (ICD-9/10) diagnostic codes. The prevalence of depression ranged widely (1.7-76.6%), as did medication non-adherence (5.9-72.9%). A meta-analysis of 17 studies and 82 059 patients showed that depression was associated with increased medication non-adherence (OR 1.48, 95% CI 1.23 to 1.78, p<0.001) using a random effects model. However, there was considerable heterogeneity between studies (I
conclusionPatients with CAD and depression may have increased odds of medication non-adherence; however, there was considerable clinical and statistical heterogeneity, underscoring the need for further research to better understand this relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.